4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-046462
EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP and General Counsel | 2024-11-06 | Sale 10b5-1 | −4,397 | $10.11 | $44,454 | 56,973 | D |
| Open-market sales · 4,397 sh · avg $10.11 · $44,454 | |||||||
Loading xslF345X05/wk-form4_1731025248.xml…